Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 149627, 21 pages
http://dx.doi.org/10.1155/2014/149627
Review Article

Functional Roles of Protein Nitration in Acute and Chronic Liver Diseases

Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, 9000 Rockville Pike, Bethesda, MD 20892-9410, USA

Received 12 February 2014; Revised 1 April 2014; Accepted 4 April 2014; Published 30 April 2014

Academic Editor: Daniela Giustarini

Copyright © 2014 Mohamed A. Abdelmegeed and Byoung-Joon Song. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Nathan, “Nitric oxide as a secretory product of mammalian cells,” The FASEB Journal, vol. 6, no. 12, pp. 3051–3064, 1992. View at Google Scholar · View at Scopus
  2. D. S. Bredt, P. M. Hwang, and S. H. Snyder, “Localization of nitric oxide synthase indicating a neural role for nitric oxide,” Nature, vol. 347, no. 6295, pp. 768–770, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Bredt and S. H. Snyder, “Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 22, pp. 9030–9033, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Koeck, X. Fu, S. L. Hazen, J. W. Crabb, D. J. Stuehr, and K. S. Aulak, “Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria,” Journal of Biological Chemistry, vol. 279, no. 26, pp. 27257–27262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Saxena and G. S. Shekhawat, “Nitric oxide (NO) in alleviation of heavy metal induced phytotoxicity and its role in protein nitration,” Nitric Oxide, vol. 32, pp. 13–20, 2013. View at Google Scholar
  7. A. Martínez-Ruiz, S. Cadenas, and S. Lamas, “Nitric oxide signaling: classical, less classical, and nonclassical mechanisms,” Free Radical Biology and Medicine, vol. 51, no. 1, pp. 17–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. B. J. Song, M. A. Abdelmegeed, L. E. Henderson et al., “Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 781050, 14 pages, 2013. View at Publisher · View at Google Scholar
  9. P. Calcerrada, G. Peluffo, and R. Radi, “Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications,” Current Pharmaceutical Design, vol. 17, no. 35, pp. 3905–3932, 2011. View at Google Scholar · View at Scopus
  10. R. Radi, J. S. Beckman, K. M. Bush, and B. A. Freeman, “Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide,” Journal of Biological Chemistry, vol. 266, no. 7, pp. 4244–4250, 1991. View at Google Scholar · View at Scopus
  11. J. R. Lancaster Jr., “Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions,” Chemical Research in Toxicology, vol. 19, no. 9, pp. 1160–1174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Caro and A. I. Cederbaum, “Oxidative stress, toxicology, and pharmacology of CYP2E1,” Annual Review of Pharmacology and Toxicology, vol. 44, pp. 27–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Purohit, B. Gao, and B.-J. Song, “Molecular mechanisms of alcoholic fatty liver,” Alcoholism: Clinical and Experimental Research, vol. 33, no. 2, pp. 191–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. I. Cohen, X. Chen, and L. E. Nagy, “Redox signaling and the innate immune system in alcoholic liver disease,” Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 523–534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. McKim, E. Gäbele, F. Isayama et al., “Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice,” Gastroenterology, vol. 125, no. 6, pp. 1834–1844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Venkatraman, S. Shiva, A. Wigley et al., “The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice,” Hepatology, vol. 40, no. 3, pp. 565–573, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Purohit, R. Rapaka, O. S. Kwon, and B. J. Song, “Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma,” Life Sciences, vol. 92, no. 1, pp. 3–9, 2013. View at Publisher · View at Google Scholar
  18. S. Bansal, C.-P. Liu, N. B. V. Sepuri et al., “Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress,” Journal of Biological Chemistry, vol. 285, no. 32, pp. 24609–24619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. A. Leclercq, G. C. Farrell, J. Field, D. R. Bell, F. J. Gonzalez, and G. R. Robertson, “CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis,” Journal of Clinical Investigation, vol. 105, no. 8, pp. 1067–1075, 2000. View at Google Scholar · View at Scopus
  20. T. Nuriel, A. Hansler, and S. S. Gross, “Protein nitrotryptophan: formation, significance and identification,” Journal of Proteomics, vol. 74, no. 11, pp. 2300–2312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Kansanen, H.-K. Jyrkkänen, and A.-L. Levonen, “Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids,” Free Radical Biology and Medicine, vol. 52, no. 6, pp. 973–982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Patel, F. Liebner, T. Netscher, K. Mereiter, and T. Rosenau, “Vitamin E chemistry. Nitration of non-α-tocopherols: products and mechanistic considerations,” Journal of Organic Chemistry, vol. 72, no. 17, pp. 6504–6512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Nakamura, R. Nagayoshi, K. Ijiri, N. Nakashima-Matsushita, T. Takeuchi, and T. Matsuyama, “Nitration and chlorination of folic acid by peroxynitrite and hypochlorous acid, and the selective binding of 10-nitro-folate to folate receptor β,” Biochemical and Biophysical Research Communications, vol. 297, no. 5, pp. 1238–1244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. B. S. Berlett, R. L. Levine, and E. R. Stadtman, “Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 2784–2789, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. L. T. Knapp, B. I. Kanterewicz, E. L. Hayes, and E. Klann, “Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C,” Biochemical and Biophysical Research Communications, vol. 286, no. 4, pp. 764–770, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Ischiropoulos, “Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species,” Archives of Biochemistry and Biophysics, vol. 356, no. 1, pp. 1–11, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Souza, E. Daikhin, M. Yudkoff, C. S. Raman, and H. Ischiropoulos, “Factors determining the selectivity of protein tyrosine nitration,” Archives of Biochemistry and Biophysics, vol. 371, no. 2, pp. 169–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Kyte and R. F. Doolittle, “A simple method for displaying the hydropathic character of a protein,” Journal of Molecular Biology, vol. 157, no. 1, pp. 105–132, 1982. View at Google Scholar · View at Scopus
  29. C. Bregere, I. Rebrin, and R. S. Sohal, “Detection and characterization of in vivo nitration and oxidation of tryptophan residues in proteins,” Methods in Enzymology, vol. 441, pp. 339–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Yamakura and H. Kawasaki, “Post-translational modifications of superoxide dismutase,” Biochimica et Biophysica Acta, vol. 1804, no. 2, pp. 318–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Deeb, T. Nuriel, C. Cheung et al., “Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 5, pp. H687–H698, 2013. View at Publisher · View at Google Scholar
  32. S. Greenacre and H. Ischiropoulos, “Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction,” Free Radical Research, vol. 34, no. 6, pp. 541–581, 2001. View at Google Scholar · View at Scopus
  33. H. Takakusa, I. Mohar, T. J. Kavanagh, E. J. Kelly, R. Kaspera, and S. D. Nelson, “Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences,” Biochemical and Biophysical Research Communications, vol. 420, no. 1, pp. 54–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Görg, M. Wettstein, S. Metzger, F. Schliess, and D. Häussinger, “Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat,” Hepatology, vol. 41, no. 5, pp. 1065–1073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Abdelmegeed, S. Jang, A. Banerjee, J. P. Hardwick, and B. J. Song, “Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury,” Free Radical Biology and Medicine, vol. 60, pp. 211–222, 2013. View at Publisher · View at Google Scholar
  36. I. Larosche, P. Lettéron, A. Berson et al., “Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase,” Journal of Pharmacology and Experimental Therapeutics, vol. 332, no. 3, pp. 886–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K.-H. Moon, B. L. Hood, B.-J. Kim et al., “Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats,” Hepatology, vol. 44, no. 5, pp. 1218–1230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. K.-H. Moon, V. V. Upreti, L.-R. Yu et al., “Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver,” Proteomics, vol. 8, no. 18, pp. 3906–3918, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H.-L. Lin, E. Myshkin, L. Waskell, and P. F. Hollenberg, “Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation,” Chemical Research in Toxicology, vol. 20, no. 11, pp. 1612–1622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Abdelmegeed, K.-H. Moon, C. Chen, F. J. Gonzalez, and B.-J. Song, “Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity,” Biochemical Pharmacology, vol. 79, no. 1, pp. 57–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Ji, I. Neverova, J. E. van Eyk, and B. M. Bennett, “Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione S-transferase by peroxynitrite,” Journal of Biological Chemistry, vol. 281, no. 4, pp. 1986–1991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. N. Savvides, M. Scheiwein, C. C. Böhme et al., “Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite,” Journal of Biological Chemistry, vol. 277, no. 4, pp. 2779–2784, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Francescutti, J. Baldwin, L. Lee, and B. Mutus, “Peroxynitrite modification of glutathione reductase: modeling studies and kinetic evidence suggest the modification of tyrosines at the glutathione disulfide binding site,” Protein Engineering, vol. 9, no. 2, pp. 189–194, 1996. View at Google Scholar · View at Scopus
  44. M. Fujimoto, N. Shimizu, K. Kunii, J. A. J. Martyn, K. Ueki, and M. Kaneki, “A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice,” Diabetes, vol. 54, no. 5, pp. 1340–1348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Reinehr, B. Görg, A. Höngen, and D. Häussinger, “CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes,” Journal of Biological Chemistry, vol. 279, no. 11, pp. 10364–10373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. S. L. Elfering, V. L. Haynes, N. J. Traaseth, A. Ettl, and C. Giulivi, “Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 1, pp. H22–H29, 2004. View at Google Scholar · View at Scopus
  47. J.-H. Z. Jian-Hong Zhu, X. Zhang, C. A. Roneker et al., “Role of copper,zinc-superoxide dismutase in catalyzing nitrotyrosine formation in murine liver,” Free Radical Biology and Medicine, vol. 45, no. 5, pp. 611–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. C. Franco, Y. Ye, C. A. Refakis et al., “Nitration of Hsp90 induces cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 12, pp. E1102–E1111, 2013. View at Publisher · View at Google Scholar
  49. F. Wu and J. X. Wilson, “Peroxynitrite-dependent activation of protein phosphatase type 2A mediates microvascular endothelial barrier dysfunction,” Cardiovascular Research, vol. 81, no. 1, pp. 38–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. J. M. Souza, G. Peluffo, and R. Radi, “Protein tyrosine nitration—functional alteration or just a biomarker?” Free Radical Biology and Medicine, vol. 45, no. 4, pp. 357–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Abello, H. A. M. Kerstjens, D. S. Postma, and R. Bischoff, “Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins,” Journal of Proteome Research, vol. 8, no. 7, pp. 3222–3238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Grune, I. E. Blasig, N. Sitte, B. Roloff, R. Haseloff, and K. J. A. Davies, “Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome,” Journal of Biological Chemistry, vol. 273, no. 18, pp. 10857–10862, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. J. M. Souza, I. Choi, Q. Chen et al., “Proteolytic degradation of tyrosine nitrated proteins,” Archives of Biochemistry and Biophysics, vol. 380, no. 2, pp. 360–366, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Schildknecht, H. R. Gerding, C. Karreman et al., “Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies,” Journal of Neurochemistry, vol. 125, no. 4, pp. 491–511, 2013. View at Publisher · View at Google Scholar
  55. C. Chavarria and J. M. Souza, “Oxidation and nitration of alpha-synuclein and their implications in neurodegenerative diseases,” Archives of Biochemistry and Biophysics, vol. 533, no. 1-2, pp. 25–32, 2013. View at Publisher · View at Google Scholar
  56. A. Ciechanover, “The ubiquitin-proteasome proteolytic pathway,” Cell, vol. 79, no. 1, pp. 13–21, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Ciechanover and A. L. Schwartz, “The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 2727–2730, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Brandon-Warner, L. W. Schrum, C. M. Schmidt, and I. H. McKillop, “Rodent models of alcoholic liver disease: of mice and men,” Alcohol, vol. 46, no. 8, pp. 715–725, 2012. View at Publisher · View at Google Scholar
  59. A. Bertola, S. Mathews, S. H. Ki, H. Wang, and B. Gao, “Mouse model of chronic and binge ethanol feeding (the NIAAA model),” Nature Protocols, vol. 8, no. 3, pp. 627–637, 2013. View at Publisher · View at Google Scholar
  60. J.-F. Wang, S. S. Greenberg, and J. J. Spitzer, “Chronic alcohol administration stimulates nitric oxide formation in the rat liver with or without pretreatment by lipopolysaccharide,” Alcoholism: Clinical and Experimental Research, vol. 19, no. 2, pp. 387–393, 1995. View at Google Scholar · View at Scopus
  61. I. G. Kessova, Y.-S. Ho, S. Thung, and A. I. Cederbaum, “Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase,” Hepatology, vol. 38, no. 5, pp. 1136–1145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. B.-J. Kim, B. L. Hood, R. A. Aragon et al., “Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells,” Proteomics, vol. 6, no. 4, pp. 1250–1260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. A. E. Feldstein, “Novel insights into the pathophysiology of nonalcoholic fatty liver disease,” Seminars in Liver Disease, vol. 30, no. 4, pp. 391–401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. A. E. Feldstein and S. M. Bailey, “Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease,” Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 421–424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. W. French, N. C. Benson, and P. S. Sun, “Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats,” Hepatology, vol. 4, no. 5, pp. 912–917, 1984. View at Google Scholar · View at Scopus
  66. H. Tsukamoto and X. P. Xi, “Incomplete compensation of enhanced hepatic oxygen consumption in rats with alcoholic centrilobular liver necrosis,” Hepatology, vol. 9, no. 2, pp. 302–306, 1989. View at Google Scholar · View at Scopus
  67. B.-J. Song, K.-H. Moon, N. U. Olsson, and N. Salem Jr., “Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids,” Journal of Hepatology, vol. 49, no. 2, pp. 262–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Suzuki, T. Murakami, R. Iino et al., “F0F1-ATPase/synthase is geared to the synthesis mode by conformational rearrangement of ε subunit in response to proton motive force and ADP/ATP balance,” Journal of Biological Chemistry, vol. 278, no. 47, pp. 46840–46846, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Radi, A. Cassina, and R. Hodara, “Nitric oxide and peroxynitrite interactions with mitochondria,” Biological Chemistry, vol. 383, no. 3-4, pp. 401–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Venkatraman, A. Landar, A. J. Davis et al., “Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity,” Journal of Biological Chemistry, vol. 279, no. 21, pp. 22092–22101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Mansouri, A. Tarhuni, I. Larosche et al., “MnSOD overexpression prevents liver mitochondrial DNA depletion after an alcohol binge but worsens this effect after prolonged alcohol consumption in mice,” Digestive Diseases, vol. 28, no. 6, pp. 756–775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. B. R. Zelickson, G. A. Benavides, M. S. Johnson et al., “Nitric oxide and hypoxia exacerbate alcohol-induced mitochondrial dysfunction in hepatocytes,” Biochimica et Biophysica Acta, vol. 1807, no. 12, pp. 1573–1582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Venkatraman, S. Shiva, A. J. Davis, S. M. Bailey, P. S. Brookes, and V. M. Darley-Usmar, “Chronic alcohol consumption increases the sensitivity of rat liver mitochondrial respiration to inhibition by nitric oxide,” Hepatology, vol. 38, no. 1, pp. 141–147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. T. M. Leung and N. Nieto, “CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, no. 2, pp. 395–398, 2013. View at Publisher · View at Google Scholar
  75. E. Albano, P. Clot, M. Morimoto, A. Tomasi, M. Ingelman-Sundberg, and S. W. French, “Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol,” Hepatology, vol. 23, no. 1, pp. 155–163, 1996. View at Publisher · View at Google Scholar · View at Scopus
  76. C. S. Lieber, “Cytochrome P-4502E1: its physiological and pathological role,” Physiological Reviews, vol. 77, no. 2, pp. 517–544, 1997. View at Google Scholar · View at Scopus
  77. Y. Lu and A. I. Cederbaum, “CYP2E1 and oxidative liver injury by alcohol,” Free Radical Biology and Medicine, vol. 44, no. 5, pp. 723–738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. M. A. Abdelmegeed, A. Banerjee, S. Jang et al., “CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis,” Free Radical Biology and Medicine, vol. 65, pp. 1238–1245, 2013. View at Publisher · View at Google Scholar
  79. K. Morgan, S. W. French, and T. R. Morgan, “Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage,” Hepatology, vol. 36, no. 1, pp. 122–134, 2002. View at Google Scholar
  80. A. Butura, K. Nilsson, K. Morgan et al., “The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model,” Journal of Hepatology, vol. 50, no. 3, pp. 572–583, 2009. View at Publisher · View at Google Scholar
  81. Y. Lu, D. Wu, X. Wang, S. C. Ward, and A. I. Cederbaum, “Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice,” Free Radical Biology and Medicine, vol. 49, no. 9, pp. 1406–1416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Knockaert, B. Fromenty, and M.-A. Robin, “Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity,” FEBS Journal, vol. 278, no. 22, pp. 4252–4260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani, “Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress,” Diabetes, vol. 53, no. 1, pp. 185–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. E. P. A. Neve and M. Ingelman-Sundberg, “Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 17130–17135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. M.-A. Robin, I. Sauvage, T. Grandperret, V. Descatoire, D. Pessayre, and B. Fromenty, “Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes,” FEBS Letters, vol. 579, no. 30, pp. 6895–6902, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. D. R. Clayburgh, L. Shen, and J. R. Turner, “A porous defense: the leaky epithelial barrier in intestinal disease,” Laboratory Investigation, vol. 84, no. 3, pp. 282–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. D. Hollander, “The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease,” Scandinavian Journal of Gastroenterology, vol. 27, no. 9, pp. 721–726, 1992. View at Google Scholar · View at Scopus
  88. A. Keshavarzian, E. W. Holmes, M. Patel, F. Iber, J. Z. Fields, and S. Pethkar, “Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol- induced liver damage,” The American Journal of Gastroenterology, vol. 94, no. 1, pp. 200–207, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Keshavarzian, S. Choudhary, E. W. Holmes et al., “Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 442–448, 2001. View at Google Scholar · View at Scopus
  90. A. Keshavarzian and J. Fields, “Alcohol: “ice-breaker” yes, “gut barrier-breaker,” maybe,” The American Journal of Gastroenterology, vol. 95, no. 5, pp. 1124–1125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Keshavarzian and J. Fields, “Alcoholic liver disease: is it an “extraintestinal” complication of alcohol-induced intestinal injury?” Journal of Laboratory and Clinical Medicine, vol. 142, no. 5, pp. 285–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. G. M. Robinson, H. Orrego, and Y. Israel, “Low-molecular-weight polyethylene glycol as a probe of gastrointestinal permeability after alcohol ingestion,” Digestive Diseases and Sciences, vol. 26, no. 11, pp. 971–977, 1981. View at Google Scholar · View at Scopus
  93. Y. Tang, A. Banan, C. B. Forsyth et al., “Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 32, no. 2, pp. 355–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. J. C. Lambert, Z. Zhou, L. Wang, Z. Song, C. J. McClain, and Y. J. Kang, “Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice,” Journal of Pharmacololgy and Experimental Therapeutics, vol. 305, no. 3, pp. 880–886, 2003. View at Publisher · View at Google Scholar
  95. J. C. Lambert, Z. Zhou, L. Wang, Z. Song, C. J. McClain, and Y. J. Kang, “Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice,” The American Journal of Pathology, vol. 164, no. 6, pp. 1959–1966, 2004. View at Publisher · View at Google Scholar
  96. C. Bode, V. Kugler, and J. C. Bode, “Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess,” Journal of Hepatology, vol. 4, no. 1, pp. 8–14, 1987. View at Google Scholar · View at Scopus
  97. Y. Tang, C. B. Forsyth, A. Farhadi et al., “Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage,” Alcoholism: Clinical and Experimental Research, vol. 33, no. 7, pp. 1220–1230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. C. B. Forsyth, R. M. Voigt, M. Shaikh et al., “Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 305, no. 2, pp. G185–G195, 2013. View at Publisher · View at Google Scholar
  99. V. V. Upreti, K.-H. Moon, L.-R. Yu et al., “Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver,” Proteomics, vol. 11, no. 2, pp. 202–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. R. L. Smathers, J. J. Galligan, B. J. Stewart, and D. R. Petersen, “Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease,” Chemico-Biological Interactions, vol. 192, no. 1-2, pp. 107–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, “Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection,” Hepatology, vol. 51, no. 5, pp. 1820–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Wieckowska, A. J. McCullough, and A. E. Feldstein, “Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future,” Hepatology, vol. 46, no. 2, pp. 582–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Aubert, K. Begriche, L. Knockaert, M. A. Robin, and B. Fromenty, “Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 10, pp. 630–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Jou, S. S. Choi, and A. M. Diehl, “Mechanisms of disease progression in nonalcoholic fatty liver disease,” Seminars in Liver Disease, vol. 28, no. 4, pp. 370–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. M. A. Abdelmegeed, A. Banerjee, S. H. Yoo, S. Jang, F. J. Gonzalez, and B. J. Song, “Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 57, no. 4, pp. 860–866, 2012. View at Publisher · View at Google Scholar
  106. S.-K. Ha and C. Chae, “Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity,” Experimental Animals, vol. 59, no. 5, pp. 595–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. N. Chalasani, J. Christopher Gorski, M. S. Asghar et al., “Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis,” Hepatology, vol. 37, no. 3, pp. 544–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. M. D. Weltman, G. C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle, “Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis,” Hepatology, vol. 27, no. 1, pp. 128–133, 1998. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Fujita, Y. Nozaki, M. Yoneda et al., “Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model,” Alcoholism: Clinical and Experimental Research, vol. 34, supplement 1, pp. S18–S24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. R. K. Seth, S. Das, A. Kumar et al., “CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis,” Toxicology and Applied Pharmacology, vol. 274, no. 1, pp. 42–54, 2014. View at Publisher · View at Google Scholar
  111. P. G. Traber and E. Zomer, “Therapy of experimental NASH and fibrosis with galectin inhibitors,” PLoS ONE, vol. 8, no. 12, Article ID e83481, 2013. View at Google Scholar
  112. W. Wang, C. Zhao, J. Zhou, Z. Zhen, Y. Wang, and C. Shen, “Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis,” PLoS ONE, vol. 8, no. 10, Article ID e76538, 2013. View at Google Scholar
  113. J. A. Solís Herruzo, I. García Ruiz, M. Pérez Carreras, and M. T. Muñoz Yagüe, “Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction,” Revista Espanola de Enfermedades Digestivas, vol. 98, no. 11, pp. 844–874, 2006. View at Google Scholar · View at Scopus
  114. E. Kathirvel, K. Morgan, S. W. French, and T. R. Morgan, “Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 9, pp. 973–983, 2009. View at Publisher · View at Google Scholar
  115. E. Kathirvel, P. Chen, K. Morgan, S. W. French, and T. R. Morgan, “Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver,” Journal of Gastroenterology and Hepatology, vol. 25, no. 6, pp. 1136–1143, 2010. View at Google Scholar
  116. R. Menghini, V. Casagrande, S. Menini et al., “TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice,” Diabetes, vol. 61, no. 2, pp. 454–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Chatterjee, D. Ganini, E. J. Tokar et al., “Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 58, no. 4, pp. 778–784, 2013. View at Publisher · View at Google Scholar
  118. X. Li, H. Li, N. Lu, Y. Feng, Y. Huang, and Z. Gao, “Iron increases liver injury through oxidative/nitrative stress in diabetic rats: involvement of nitrotyrosination of glucokinase,” Biochimie, vol. 94, no. 12, pp. 2620–7262, 2012. View at Publisher · View at Google Scholar
  119. P. Solís-Muñoz, J. A. Solís-Herruzo, D. Fernández-Moreira et al., “Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice,” Journal of Pineal Research, vol. 51, no. 1, pp. 113–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Charbonneau and A. Marette, “Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins,” Diabetes, vol. 59, no. 4, pp. 861–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Miyagi, H. Sakaguchi, R. M. Darrow et al., “Evidence that light modulates protein nitration in rat retina,” Molecular & Cellular Proteomics, vol. 1, no. 4, pp. 293–303, 2002. View at Google Scholar · View at Scopus
  122. H.-J. C. Chen, C.-M. Chang, W.-P. Lin, D.-L. Cheng, and M.-I. Leong, “H2O2/nitrite-induced post-translational modifications of human hemoglobin determined by mass spectrometry: redox regulation of tyrosine nitration and 3-nitrotyrosine reduction by antioxidants,” ChemBioChem, vol. 9, no. 2, pp. 312–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. H.-J. C. Chen, C.-M. Chang, and Y.-M. Chen, “Hemoprotein-mediated reduction of nitrated DNA bases in the presence of reducing agents,” Free Radical Biology and Medicine, vol. 34, no. 2, pp. 254–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Kamisaki, K. Wada, K. Bian et al., “An activity in rat tissues that modifies nitrotyrosine-containing proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 20, pp. 11584–11589, 1998. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. Irie, M. Saeki, Y. Kamisaki, E. Martin, and F. Murad, “Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 5634–5639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  126. W.-N. Kuo, R. N. Kanadia, V. P. Shanbhag, and R. Toro, “Denitration of peroxynitrite-treated proteins by “protein nitratases” from rat brain and heart,” Molecular and Cellular Biochemistry, vol. 201, no. 1-2, pp. 11–16, 1999. View at Google Scholar · View at Scopus
  127. B. Görg, N. Qvartskhava, P. Voss, T. Grune, D. Häussinger, and F. Schliess, “Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration,” FEBS Letters, vol. 581, no. 1, pp. 84–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. H. S. Smallwood, N. M. Lourette, C. B. Boschek et al., “Identification of a denitrase activity against calmodulin in activated macrophages using high-field liquid chromatography—FTICR mass spectrometry,” Biochemistry, vol. 46, no. 37, pp. 10498–10505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Kang and H. I. Akbarali, “Denitration of L-type calcium channel,” FEBS Letters, vol. 582, no. 20, pp. 3033–3036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. L. C. Godoy, C. Muñoz-Pinedo, L. Castro et al., “Disruption of the M80-Fe ligation stimulates the translocation of cytochrome c to the cytoplasm and nucleus in nonapoptotic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2653–2658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. H. B. Eccleston, K. K. Andringa, A. M. Betancourt et al., “Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice,” Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 447–459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. S. Annie-Jeyachristy, A. Geetha, R. Surendran et al., “Level of nitrated proteins in the plasma, platelets and liver of patients with liver cirrhosis,” Redox Report, vol. 14, no. 6, pp. 259–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. A. Spruss, G. Kanuri, K. Uebel, S. C. Bischoff, and I. Bergheim, “Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice,” Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2121–2135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  134. M. A. Abdelmegeed, S.-H. Yoo, L. E. Henderson, F. J. Gonzalez, K. J. Woodcroft, and B.-J. Song, “PPARα expression protects male mice from high fat-induced nonalcoholic fatty liver,” Journal of Nutrition, vol. 141, no. 4, pp. 603–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Wagnerberger, A. Spruss, G. Kanuri et al., “Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis,” The British Journal of Nutrition, vol. 107, no. 12, pp. 1727–1738, 2012. View at Publisher · View at Google Scholar
  136. I. Locatelli, S. Sutti, M. Vacchiano, C. Bozzola, and E. Albano, “NF-kappaB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses,” Clinical Science, vol. 124, no. 4, pp. 279–287, 2013. View at Publisher · View at Google Scholar
  137. A. Banerjee, M. A. Abdelmegeed, S. Jang, and B. J. Song, “Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators,” PLoS ONE, vol. 8, no. 10, Article ID e76850, 2013. View at Google Scholar
  138. K. Begriche, A. Igoudjil, D. Pessayre, and B. Fromenty, “Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it,” Mitochondrion, vol. 6, no. 1, pp. 1–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. S. H. Yoo, O. Park, L. E. Henderson, M. A. Abdelmegeed, K.-H. Moon, and B.-J. Song, “Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress,” Toxicology Letters, vol. 202, no. 1, pp. 23–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. K.-H. Moon, B. L. Hood, P. Mukhopadhyay et al., “Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion,” Gastroenterology, vol. 135, no. 4, pp. 1344–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. J. A. Hinson, S. L. Pike, N. R. Pumford, and P. R. Mayeux, “Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice,” Chemical Research in Toxicology, vol. 11, no. 6, pp. 604–607, 1998. View at Publisher · View at Google Scholar · View at Scopus
  142. T. R. Knight, Y.-S. Ho, A. Farhood, and H. Jaeschke, “Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione,” Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 2, pp. 468–475, 2002. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Cover, A. Mansouri, T. R. Knight et al., “Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity,” Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 2, pp. 879–887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. A. J. Gow, D. Duran, S. Malcolm, and H. Ischiropoulos, “Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation,” FEBS Letters, vol. 385, no. 1-2, pp. 63–66, 1996. View at Publisher · View at Google Scholar · View at Scopus
  145. B. S. Berlett, B. Friguet, M. B. Yim, P. B. Chock, and E. R. Stadtman, “Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 5, pp. 1776–1780, 1996. View at Publisher · View at Google Scholar · View at Scopus
  146. R. Agarwal, L. A. MacMillan-Crow, T. M. Rafferty et al., “Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 1, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. H.-M. Ni, A. Bockus, N. Boggess, H. Jaeschke, and W.-X. Ding, “Activation of autophagy protects against acetaminophen-induced hepatotoxicity,” Hepatology, vol. 55, no. 1, pp. 222–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. V. O. Kitam, O. V. Maksymchuk, and M. O. Chashchyn, “The possible mechanisms of CYP2E1 interactions with HSP90 and the influence of ethanol on them,” BMC Structural Biology, vol. 12, article 33, 2012. View at Google Scholar
  149. A. Dey and A. I. Cederbaum, “Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathway,” Archives of Biochemistry and Biophysics, vol. 461, no. 2, pp. 275–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. A. Dey and A. I. Cederbaum, “Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 3, pp. 1391–1399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Vadseth, J. M. Souza, L. Thomson et al., “Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 8820–8826, 2004. View at Publisher · View at Google Scholar · View at Scopus
  152. B. I. Giasson, J. E. Duda, I. V. J. Murray et al., “Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions,” Science, vol. 290, no. 5493, pp. 985–989, 2000. View at Publisher · View at Google Scholar · View at Scopus
  153. H. Ahsan, “3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions,” Human Immunology, vol. 74, no. 10, pp. 1392–1399, 2013. View at Publisher · View at Google Scholar
  154. H. Ohmori and N. Kanayama, “Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins,” Autoimmunity Reviews, vol. 4, no. 4, pp. 224–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  155. H. C. Birnboim, A.-M. Lemay, D. K. Y. Lam, R. Goldstein, and J. R. Webb, “Cutting edge: MHC class ii-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response,” Journal of Immunology, vol. 171, no. 2, pp. 528–532, 2003. View at Google Scholar · View at Scopus
  156. L. Thomson, J. Christie, C. Vadseth et al., “Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma,” The American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 2, pp. 152–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  157. S. Nagaraj, K. Gupta, V. Pisarev et al., “Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer,” Nature Medicine, vol. 13, no. 7, pp. 828–835, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. L. L. Hardy, D. A. Wick, and J. R. Webb, “Conversion of tyrosine to the inflammation-associated analog 3°-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells,” Journal of Immunology, vol. 180, no. 9, pp. 5956–5962, 2008. View at Google Scholar · View at Scopus
  159. R. K. Monroe and S. W. Halvorsen, “Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption,” NeuroToxicology, vol. 30, no. 4, pp. 589–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  160. M. Kurdi and G. W. Booz, “JAK redux: a second look at the regulation and role of JAKs in the heart,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 5, pp. H1545–H1556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. M. D. Gole, J. M. Souza, I. Choi et al., “Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 278, no. 5, pp. L961–L967, 2000. View at Google Scholar · View at Scopus
  162. S. K. Mantena, D. P. Vaughn Jr., K. K. Andringa et al., “High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo,” Biochemical Journal, vol. 417, no. 1, pp. 183–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Boveris and B. Chance, “The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen,” Biochemical Journal, vol. 134, no. 3, pp. 707–716, 1973. View at Google Scholar · View at Scopus
  164. B. Fromenty and D. Pessayre, “Impaired mitochondrial function in microvesicular steatosis: effects of drugs, ethanol, hormones and cytokines,” Journal of Hepatology, vol. 26, supplement 2, pp. 43–53, 1997. View at Google Scholar · View at Scopus
  165. D. Pessayre, A. Mansouri, and B. Fromenty, “Nonalcoholic steatosis and steatohepatitis V. mitochondrial dysfunction in steatohepatitis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 282, no. 2, pp. G193–G199, 2002. View at Google Scholar · View at Scopus
  166. R. B. Hamanaka and N. S. Chandel, “Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes,” Trends in Biochemical Sciences, vol. 35, no. 9, pp. 505–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. B.-J. Song, K.-H. Moon, V. V. Upreti, N. D. Eddington, and I. J. Lee, “Mechanisms of mdma (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage,” Current Pharmaceutical Biotechnology, vol. 11, no. 5, pp. 434–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. K. B. Wallace, “Mitochondrial off targets of drug therapy,” Trends in Pharmacological Sciences, vol. 29, no. 7, pp. 361–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. S. M. Bailey, E. C. Pietsch, and C. C. Cunningham, “Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III,” Free Radical Biology and Medicine, vol. 27, no. 7-8, pp. 891–900, 1999. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Giulivi, “Characterization and function of mitochondrial nitric-oxide synthase,” Free Radical Biology and Medicine, vol. 34, no. 4, pp. 397–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  171. Y. M. W. Janssen-Heininger, B. T. Mossman, N. H. Heintz et al., “Redox-based regulation of signal transduction: principles, pitfalls, and promises,” Free Radical Biology and Medicine, vol. 45, no. 1, pp. 1–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  172. E. Ford, M. N. Hughes, and P. Wardman, “Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH,” Free Radical Biology and Medicine, vol. 32, no. 12, pp. 1314–1323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  173. J. C. Fernández-Checa, N. Kaplowitz, C. García-Ruiz, and A. Colell, “Mitochondrial glutathione: importance and transport,” Seminars in Liver Disease, vol. 18, no. 4, pp. 389–401, 1998. View at Google Scholar · View at Scopus
  174. K. J. A. Davies and R. Shringarpure, “Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases,” Neurology, vol. 66, no. 2, supplement 1, pp. S93–S96, 2006. View at Google Scholar · View at Scopus
  175. A. M. Pickering and K. J. Davies, “Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins,” Archives of Biochemistry and Biophysics, vol. 523, no. 2, pp. 181–190, 2012. View at Publisher · View at Google Scholar
  176. A. M. Pickering and K. J. Davies, “Degradation of damaged proteins: the main function of the 20S proteasome,” Progress in Molecular Biology and Translational Science, vol. 109, pp. 227–248, 2012. View at Publisher · View at Google Scholar
  177. S. H. Caldwell, L. A. R. de Freitas, S. H. Park et al., “Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis,” Hepatology, vol. 49, no. 6, pp. 1888–1895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. S. Campello and L. Scorrano, “Mitochondrial shape changes: orchestrating cell pathophysiology,” EMBO Reports, vol. 11, no. 9, pp. 678–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. B.-J. Song, M. A. Abdelmegeed, S.-H. Yoo et al., “Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications,” Journal of Proteomics, vol. 74, no. 12, pp. 2691–2702, 2011. View at Publisher · View at Google Scholar · View at Scopus
  180. D. Chandra and K. K. Singh, “Genetic insights into OXPHOS defect and its role in cancer,” Biochimica et Biophysica Acta, vol. 1807, no. 6, pp. 620–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  181. J. Wan, M.-A. Bae, and B.-J. Song, “Acetoaminophen-induced accumulation of 8-oxodeoxyguanosine through reduction of Ogg1 DNA repair enzyme in C6 glioma cells,” Experimental and Molecular Medicine, vol. 36, no. 1, pp. 71–77, 2004. View at Google Scholar · View at Scopus
  182. M. Monsalve, S. Borniquel, I. Valle, and S. Lamas, “Mitochondrial dysfunction in human pathologies,” Frontiers in Bioscience, vol. 12, no. 3, pp. 1131–1153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  183. A. Mansouri, B. Fromenty, A. Berson et al., “Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients,” Journal of Hepatology, vol. 27, no. 1, pp. 96–102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  184. A. Mansouri, I. Gaou, C. de Kerguenec et al., “An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice,” Gastroenterology, vol. 117, no. 1, pp. 181–190, 1999. View at Publisher · View at Google Scholar · View at Scopus
  185. W.-X. Ding, M. Li, and X.-M. Yin, “Selective taste of ethanol-induced autophagy for mitochondria and lipid droplets,” Autophagy, vol. 7, no. 2, pp. 248–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  186. C. S. Lieber, “Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis,” Alcohol, vol. 34, no. 1, pp. 9–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  187. B. Gao and R. Bataller, “Alcoholic liver disease: pathogenesis and new therapeutic targets,” Gastroenterology, vol. 141, no. 5, pp. 1572–1585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  188. M. T. Lin and M. F. Beal, “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases,” Nature, vol. 443, no. 7113, pp. 787–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  189. K. S. Aulak, T. Koeck, J. W. Crabb, and D. J. Stuehr, “Proteomic method for identification of tyrosine-nitrated proteins,” Methods in Molecular Biology, vol. 279, pp. 151–165, 2004. View at Google Scholar · View at Scopus
  190. L. A. Macmillan-Crow and J. A. Thompson, “Immunoprecipitation of nitrotyrosine-containing proteins,” Methods in Enzymology, vol. 301, pp. 135–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  191. M. Helman and D. Givol, “Isolation of nitrotyrosine-containing peptides by using an insoluble-antibody column,” Biochemical Journal, vol. 125, no. 4, pp. 971–974, 1971. View at Google Scholar · View at Scopus
  192. H. F. G. Heijnen, E. van Donselaar, J. W. Slot et al., “Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase,” Free Radical Biology and Medicine, vol. 40, no. 11, pp. 1903–1913, 2006. View at Publisher · View at Google Scholar · View at Scopus
  193. F. Dekker F, N. Abello, R. Wisastra, and R. Bischoff, “Enrichment and detection of tyrosine-nitrated proteins,” in Current Protocols in Protein Science, Chapter 14: Unit 14.3, 2012. View at Google Scholar
  194. Q. Zhang, W.-J. Qian, T. V. Knyushko et al., “A method for selective enrichment and analysis of nitrotyrosine-containing peptides in complex proteome samples,” Journal of Proteome Research, vol. 6, no. 6, pp. 2257–2268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  195. D. Tsikas and K. Caidahl, “Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 814, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  196. L. Anderon, “Candidate-based proteomics in the search for biomarkers of cardiovascular disease,” Journal of Physiology, vol. 563, part 1, pp. 23–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  197. X. Zhan and D. M. Desiderio, “The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional western blotting, and amino acid sequence determination with mass spectrometry,” Biochemical and Biophysical Research Communications, vol. 325, no. 4, pp. 1180–1186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  198. L. Zheng, M. Settle, G. Brubaker et al., “Localization of nitration and chlorination sites on apolipoprotein A-I catalysed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages,” Journal of Biological Chemistry, vol. 280, no. 1, pp. 38–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  199. Y. K.-C. Butt and S. C.-L. Lo, “Detecting nitrated proteins by proteomic technologies,” Methods in Enzymology, vol. 440, pp. 17–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  200. D. Tsikas, M. Schmidt, A. Bohmer, A. A. Zoerner, F. M. Gutzki, and J. Jordan, “UPLC-MS/MS measurement of S-nitrosoglutathione (GSNO) in human plasma solves the S-nitrosothiol concentration enigma,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 927, pp. 147–157, 2013. View at Publisher · View at Google Scholar
  201. D. B. Pho, C. Roustan, A. N. T. Tot, and L.-A. Pradel, “Evidence for an essential glutamyl residue in yeast hexokinase,” Biochemistry, vol. 16, no. 20, pp. 4533–4537, 1977. View at Google Scholar · View at Scopus
  202. X. Zhan and D. M. Desiderio, “Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry,” Analytical Biochemistry, vol. 354, no. 2, pp. 279–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  203. B.-J. Song, R. L. Veech, S. S. Park, H. V. Gelboin, and F. J. Gonzalez, “Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization,” Journal of Biological Chemistry, vol. 264, no. 6, pp. 3568–3572, 1989. View at Google Scholar · View at Scopus
  204. C. Saito, J. J. Lemasters, and H. Jaeschke, “C-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 246, no. 1-2, pp. 8–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  205. H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters, “Mechanisms of hepatotoxicity,” Toxicological Sciences, vol. 65, no. 2, pp. 166–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  206. G. Li, J. B. Chen, C. Wang et al., “Curcumin protects against acetaminophen-induced apoptosis in hepatic injury,” World Journal of Gastroenterology, vol. 19, no. 42, pp. 7440–7446, 2013. View at Publisher · View at Google Scholar
  207. A. Ramachandran, M. Lebofsky, S. A. Weinman, and H. Jaeschke, “The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 251, no. 3, pp. 226–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  208. N. R. Carvalho, E. F. da Rosa, M. H. da Silva et al., “New therapeutic approach: diphenyl diselenide reduces mitochondrial dysfunction in acetaminophen-induced acute liver failure,” PLoS ONE, vol. 8, no. 12, Article ID e81961, 2013. View at Google Scholar
  209. A. S. Burke, L. A. MacMillan-Crow, and J. A. Hinson, “Reactive nitrogen species in acetaminophen-induced mitochondrial damage and toxicity in mouse hepatocytes,” Chemical Research in Toxicology, vol. 23, no. 7, pp. 1286–1292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. S. Soboll, “Regulation of energy metabolism in liver,” Journal of Bioenergetics and Biomembranes, vol. 27, no. 6, pp. 571–582, 1995. View at Publisher · View at Google Scholar · View at Scopus
  211. B. Fromenty and D. Pessayre, “Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity,” Pharmacology and Therapeutics, vol. 67, no. 1, pp. 101–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  212. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer, “Molecular mechanisms of necroptosis: an ordered cellular explosion,” Nature Reviews Molecular Cell Biology, vol. 11, no. 10, pp. 700–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  213. S. M. Bailey, G. Robinson, A. Pinner et al., “S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 291, no. 5, pp. G857–G867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  214. A. S. Darvesh, R. T. Carroll, A. Bishayee, W. J. Geldenhuys, and C. J. van der Schyf, “Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents,” Expert Review of Neurotherapeutics, vol. 10, no. 5, pp. 729–745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  215. H.-L. Ha, H.-J. Shin, M. A. Feitelson, and D.-Y. Yu, “Oxidative stress and antioxidants in hepatic pathogenesis,” World Journal of Gastroenterology, vol. 16, no. 48, pp. 6035–6043, 2010. View at Publisher · View at Google Scholar · View at Scopus
  216. M.-Y. Chung, H. J. Park, J. E. Manautou, S. I. Koo, and R. S. Bruno, “Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes,” Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 361–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  217. G. Musso, R. Gambino, F. de Michieli et al., “Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin a intake,” The American Journal of Clinical Nutrition, vol. 86, no. 3, pp. 661–671, 2007. View at Google Scholar · View at Scopus
  218. P. L. Horvatovich and R. Bischoff, “Current technological challenges in biomarker discovery and validation,” European Journal of Mass Spectrometry, vol. 16, no. 1, pp. 101–121, 2010. View at Publisher · View at Google Scholar · View at Scopus